Silver nanoparticles (AgNPs) have been extensively studied because of their antimicrobial potential. Here, we evaluated the effect of biologically synthesized silver nanoparticles (AgNP bio ) alone and in combination with fluconazole (FLC) against planktonic cells and biofilms of FLC-resistant Candida albicans. AgNP bio exhibited a fungicidal effect, with a minimal inhibitory concentration (MIC) and fungicidal concentration ranging from 2.17 to 4.35 µg/ml. The combination of AgNP bio and FLC reduced the MIC of FLC around 16 to 64 times against planktonic cells of all C. albicans. There was no significant inhibitory effect of AgNP bio on biofilm cells. However, FLC combined with AgNP bio caused a significant dose-dependent decrease in the viability of both initial and mature biofilm. All concentrations of AgNP bio, alone or in combination with FLC, were not cytotoxic to mammalian cells.
Introduction
Candida albicans is the leading cause of opportunistic mycoses worldwide [1] . Crucially, this species is frequently associated with biofilm formation on biotic surfaces and implanted medical devices [2] , which can contribute to a high mortality rate among infected patients [2] . Besides, the emergence of fluconazole (FLC)-resistant isolates has been observed in the last decades [1] .
Currently, several approaches have been examined to overcome reduced susceptibility of Candida to FLC [3] . Recent advances in nanotechnology have stirred interest in the application of metallic nanoparticles in medicine. Because of their antimicrobial properties [4, 5] , silver nanoparticles (AgNPs) have been investigated alone or in combination with other compounds [6, 7] .
Here, the antifungal potential of biologically synthesized AgNPs (AgNP bio ) alone or in combination with FLC was investigated against planktonic cells and biofilm of FLCresistant C. albicans.
Materials and methods

Microorganisms and culture conditions
Candida albicans ATCC 26790 and oral FLC-resistant C. albicans isolates from healthy (isolate E) and diabetic (isolate 122) individuals seen in a primary healthcare unit in Maringá city, Paraná, Brazil in 2011 were used in this study. Minimum inhibitory concentration (MIC) of FLC (Sigma Chemical Co, USA) was previously determined by standard broth microdilution method, using M27-S4 recommendations [8] . All yeasts were maintained at −80 o C in Sabouraud dextrose broth (Himedia, India) containing 30% glycerol. The protocols were approved by the Ethics Committee of Uningá (CEP no. 0017/11).
Synthesis of AgNP bio
AgNP bio were freshly biosynthesized as previously described [9] . Briefly, Fusarium oxysporum (strain 551) biomass (10 g) was added to 100 ml of distilled water and incubated for 72 hours at 28
• C. The culture was filtered, and the filtrate was mixed with AgNO 3 (1.0 mM; SigmaAldrich, USA) and kept at 28
• C for 28 hours. AgNP bio were characterized by scanning electron microscopy and energydispersive spectroscopy [9] .
Antifungal susceptibility testing on planktonic cells
The MIC of FLC (range used: 0.25-128 µg/ml) and AgNP bio (range used: 0.28-8.7 µg/ml) was determined by the standard broth microdilution method with minor modifications [8] . In all antifungal susceptibility assays, the test medium was RPMI 1640 buffered with 0.165 M 3-(Nmorpholino) propanesulfonic acid (RPMI). The effect of combinations of FLC (0.25-128 µg/ml) with nanoparticles (0.28-8.7 µg/ml) on planktonic cells was assessed by the checkerboard method [10] . Briefly, the yeast cell inoculum was set according to standard protocols [8] , the dilution of each compound was placed in wells of microtiter plate to provide 80 combinations. In addition, MIC of compounds alone was also determined. The results were interpreted using the fractional inhibitory concentration index (FICI). FICI values classified the combination as: ≤0.5, synergy; >0.5 to 4.0, no interaction; ≥4.0, antagonism [11] . The MIC values of compounds alone or in combination were read visually at 24 hours of incubation and were defined as the lowest concentration that resulted in a visible decrease of turbidity compared to compound-free growth control. For time-kill curve analysis, 1 × 10 6 CFU/ml of all Candida yeasts were incubated with each compound at previously determined MIC values in RPMI, alone or in combination. At 0, 2, 4, 8, 16, 24 hour time points, aliquots were inoculated on SDA and incubated at 37 o C for 24 hours. Candida growth without any compound was used as control (CTR). For viability analyses, 1 × 10 6 CFU/ml in RPMI were incubated with each compound at MIC values, alone or in combination for 2 hours, treated and untreated cells were washed with PBS and stained with FUN-1 dye using the LIVE/DEAD yeast viability kit (Molecular Probes, USA), following the manufacturer's recommendation. Cell viability was analyzed by fluorescence microscopy (Leica DM2000) using fluorescein filters. All assays were carried out in triplicate on three different occasions.
Inhibition of biofilm formation assay
Candida biofilms were formed in flat-bottomed 96-well plates as previously described [12] . After 1.5 and 24 hours of biofilm formation, the medium was aspirated off and each well was washed with PBS. RPMI (200 µl), containing AgNP bio (2.17 or 4.75 µg/ml) alone or in combination with serial twofold dilutions of FLC (128-2 µg/ml), was added, and the plates were further incubated for 24 hours at 37
• C. Viability of biofilms was determined using the 2,3-bis(2-methoxy-4-nitro-5-sulfo-phenyl)-2H-tetrazolium-5-carboxanilide (XTT)-reduction assay [12] . Briefly, a 100 µl aliquot of XTT-menadione (0.1 mg/ml XTT and 1 µM menadione, Sigma Chemical Co, USA) was added and the plates incubated in the dark for 2 hours at 37
• C. The product formed was measured at 490 nm with microtiter plate reader (Synergy HT, Biotek, USA). All assays were carried out in triplicate on three different occasions.
Cytotoxicity assay
The cytotoxicity of AgNP bio alone or in combination with FLC was determined as described by Marcato et al. [13] 
Statistical analysis
The results were analyzed by one-way ANOVA using Graphpad Prism version 6.0 (Graphpad Software).
Comparative analysis was performed using Tukey's test. P < 0.05 was considered significant.
Results
In this study, AgNP bio produced by F. oxysporum were evaluated for their effect against FLC-resistant C. albicans. According to FICI, no synergistic effect was observed when AgNP bio and FLC were combined in this study. However, the combinations caused a marked reduction in FLC MIC (around 16 to 64 times) for all C. albicans strains (Table 1) . Interestingly, the effect of AgNP bio on planktonic cells of C. albicans appeared to be time dependent and fungicidal in contrast to the fungistatic effect of FLC. In combination with FLC, a significant reduction in CFU count was observed after 2 hours, and no CFU were detected after 4 hours. With AgNP bio alone, total cell death was observed after 24 hours (Fig. 1A) . Microscopy showed that yeasts exhibited a green-fluorescent staining, reflecting dead cells after 2 hours in the presence of FLC and AgNP bio combined, which corroborated the effects on CFU counts (Fig. 1B) . FLC-resistant C. albicans isolates (E and 122) also presented similar effects (data not shown). When AgNP bio was tested on biofilm, no significant effect at 2.17 or 4.35 µg/ml AgNP bio was observed, but the combination with FLC caused a significant (P < .001) FLC dose-dependent decrease in viability of these cells after 24 hours. For both concentrations, the effect was more pronounced during the initial phases of biofilm formation (Table 2) . Comparable effects on FLC-resistant C. albicans isolates were obtained (data not shown). No AgNP bio and FLC combination showed a cytotoxic effect on HEp-2 cells, as judged by the cell viability remaining higher than 50% after 24 hours (data not shown).
Discussion
Here, an eco-friendly AgNP bio produced by F. oxysporum was shown to have fungicidal effect against FLCresistant C. albicans, with no cytotoxicity to mammalian cells. This inhibitory effect of AgNP bio on FLC-susceptible C. albicans had been previously described [14, 15] . Similar to our results, Ishida et al. [5] reported a fungicidal effect of AgNP bio produced by F. oxysporum on C. albicans, with MIC and MFC values of 1.68 and 3.40 µg/ml, respectively. Cytotoxic concentration of AgNP bio found for HEp-2 cells was similar to Marcato et al. [13] . Besides, Lima et al. also showed noncytotoxicity up to a concentration of 10 µg/ml of silver biogenic nanoparticles on 3T3 cells [16] . Interestingly, our results highlight the decrease of FLC MIC of FLC-resistant C. albicans when combined to AgNP bio . The resistance to FLC in C. albicans is strongly associated with overexpression of genes encoding efflux pumps or lanosterol 14α-demethylase [17] . On the other hand, the mechanisms of C. albicans death induced by AgNPs are not completely understood. AgNP-treated C. albicans exhibits a disrupted cell wall and cytoplasmic membrane [15] . In addition, AgNPs cause an increase in reactive oxygen species and hydroxyl radical production, which can also contribute to cell membrane damage [18] . Since AgNP bio can alter the permeability of the cell membrane, we can hypothesize that they may facilitate the entry of FLC, which interferes with ergosterol biosynthesis.
Regarding the effect of AgNP bio effect against biofilm, previous studies have shown an antifungal effect of chemically produced AgNPs in initial stages of biofilm formation of C. albicans [4] , in contrast to our results. In addition, AgNP bio was not able to inhibit the mature biofilm of yeasts at the concentrations tested here, but their combination with FLC reduced the viability of biofilm in a dosedependent manner. Importantly, silver nanoparticles produced by F. oxysporum are stable for several months due to protein capping, which occurs in the biogenic process, as observed by transmission electron microscopy [19] . Therefore, these results indicate the potential of AgNP bio for the development of new strategies for the treatment of FLCresistant C. albicans infections. Further studies are needed to establish the mechanism of yeast death and the usefulness of AgNP bio in medicine. 
